COVID-19 Rush Journal Club Archives - By Topic

Browse all articles reviewed by topic; click the headings to open the current edition for each topic in a new tab or window.

Public Health

  • National trends in the US public’s likelihood of getting a COVID-19 vaccine- April 1 to December 8, 2020. (Review by Melissa Porterhouse, MS1)

  • Association of smoking and cumulative park-year exposure with COVID-19 outcomes in the Cleveland Clinic COVID-19 Registry (Review by Robert Roth, MS1)

  • Reports of Forgone Medical Care Among US Adults During the Initial Phase of the COVID-19 Pandemic (Review by Kate Tehaney, MS2)

  • Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic. (Review by Kat Tehaney, MS2)

  • Immediate impact of stay-at-home orders to control COVID-19 transmission on socioeconomic conditions, food insecurity, mental health, and intimate partner violence in Bangladeshi women and their families: an interrupted time series ((Review by Mohammed Abdul Sami, MS1)

  • Association of Political Party Affiliation With Physical Distancing Among Young Adults During the COVID-19 Pandemic (Review by Melissa Porterhouse, MS1) 

  • Change in Reported Adherence to Nonpharmaceutical Interventions During the COVID-19 Pandemic, April-November 2020 (Review by Melissa Porterhouse, MS1)

  • Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study (Review by Mohammed Abdul Sami, MS1)

  • Assessment of SARS-CoV-2 RNA Test Results Among Patients Who Recovered from COVID-19 With Prior Negative Results (Review by Christopher Szewczyk, MS1)

  • Risk of severe COVID-19 among workers and their household members. (Robert Roth, MS1)  

  • Trends in Outpatient Care Delivery and Telemedicine During the COVID-19 Pandemic in the US (Review by Mohammed Abdul Sami, MS1)  

  • Psychological Distress and COVID-19-Related Stressors Reported in a Longitudinal Cohort of US Adults in April and July 2020 (Review by Carter Do, MS1) 

  • Peripheral Oxygen Saturation in Older Persons Wearing Nonmedical Face Masks in Community Settings (Review by Amanda Narkis, M3)

  • Nonfatal Opioid Overdoses at an Urban Emergency Department During the COVID-19 Pandemic (Review by: Emilie Rembert, M1)

  • Analysis of Drug Test Results Before and After the US Declaration of a National Emergency Concerning the COVID-19 Outbreak (Review by Emilie Rembert, M1)

  • Spatial analysis of COVID-19 clusters and contextual factors in New York City. (Review by Ashley Wehrheim, MS3)

  • The association of race and COVID-19 mortality (Review by Ashley Wehrheim, MS3)

  • The impact of ethnicity on clinical outcomes in COVID-19: A systematic review (Review by Ashley Wehrheim, MS3)

  • Economic Vulnerability of Households With Essential Workers (Review by Mohammed Abdul Sami, M1)

  • SARS-CoV-2 Positivity Rate for Latinos in the Baltimore-Washington, DC Region (Review by Ashley Wehrheim, MS3)

  • School closure and management practices during coronavirus outbreaks including COVID-19 (Review by Josh Doppelt, MS4)

  • Covid-19: control measures must be equitable and inclusive (Reviewed by Laura Hurley, MS3)

  • COVID-19 and African Americans (Review by Eiftu Haile, MS4)

  • A Brief Telephone Severity Scoring System and Therapeutic Living Centers Solved Acute Hospital-Bed Shortage during the COVID-19 Outbreak in Daegu, Korea. (Review by Josh Doppelt, MD)

  • The Untold Toll—The Pandemic’s Effects on Patients without Covid-19. (Review by Laura Hurley, MS3)

  • Perceptions and behavioural responses of the general public during the COVID-19 pandemic: Cross-sectional survey of UK adults. (Review by Katherine Tehaney, MS1)

  • Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset. (Review by Josh Doppelt, MD)

  • First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. (Review by Josh Doppelt, MD)

  • Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs. (Review by Josh Doppelt, MD)

  • Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modeling study. (Review by Kat Tehaney, MS1)

  • Awareness, Attitudes, and Actions Related to COVID-19 Among Adults with Chronic Conditions at the Onset of the U.S. Outbreak. (Review by Timothy Huang, MS1)

  • COVID-19 and smoking: A systematic review of the evidence. (Review by Kelly Harmon, MS1 )

  • Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. (Review by Kelly Harmon, MS1 )

  • Does Comorbidity Increase the Risk of Patients With COVID-19: Evidence from Meta-Analysis. (Review by Kelly Harmon, MS1 )

  • Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. (Review by Kat Tehaney, MS1)

  • Mental Health Status Among Children in Home Confinement During the Coronavirus Disease 2019 Outbreak in Hubei Province, China. (Review by Kat Tehaney, MS1)

  • Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020 (Review by Eiftu Haile, MD)

  • COVID-19 in Prisons and Jails in the United States. (Review by Alice Burgess, MS2)

  • Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review (Review by Kelly Harmon, MS1)

  • Internet Searches for Unproven COVID-19 Therapies in the United States (Review by Kat Tehaney, MS1)

  • An interpretable mortality prediction model for COVID-19 patients (Review by Kat Tehaney, MS1)

  • Diabetes and COVID-19: Psychosocial Consequences of the COVID-19 Pandemic in People With Diabetes in Denmark-what Characterizes People With High Levels of COVID-19-related Worries? (Review by Kat Tehaney, MS1)

  • Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019 (Review by Kat Tehaney, MS1)

  • To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 Pandemic. (Review by Kaitlyn Wehrheim, MS3)

  • Associations between Built Environment, Neighborhood, Socioeconomic Status, and SARS-CoV-2 Infection among Pregnant Women (Review by Ashley Wehrheim, MS3)

  • The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission (Review by Bijan Zarrabi, MS2)

  • A rapid systematic review of the efficacy of face masks and respiratory against coronavirus and other respiratory transmissible Viruses (Review by Ashley Wehrheim, MS3)

  • Hospitalization and Mortality among Black Patients and White Patients with Covid-19 (Review by Ashley Wehrheim, MS3)

Back to top


Biology

  • Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion (Robert Roth, MS1)  

  • Multiorgan and Renal Tropism of SARS-CoV-2 (Review by Robert Roth, MS1)

  • SARS-CoV-2 infection protects against rechallenge in rhesus macaques (Review by Abigail Bawden, MS2)

  • Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts (Review by Abigail Bawden, MS2)

  • A pneumonia outbreak associated with a new coronavirus of probable bat origin (Review by Abigail Bawden, MS2)

  • Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding (Review by Beth Hall, MS4)

  • Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19. (Review by Jackie Urban, MS4)

  • Structural and functional basis of SARS-CoV-2 entry by using human ACE2. (Review by Emily Hejna)

  • Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2 (Review by Alexandra Feldner, MS3)

  • Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV (Review by Abigail Bawden, MS1)

  • Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation (Review by Luke McCormack, MS2)

  • Structure of Mpro from COVID-19 virus and discovery of its inhibitors (Review by Luke McCormack, MS2)

  • Structure of the RNA-dependent RNA Polymerase from COVID-19 Virus (Review by Ndubisi Onah, MS3)

  • Is low alveolar type II cell SOD3 in the lungs of elderly linked to the observed severity of COVID-19? (Review by Jackie Urban, MS4)

  • Visualizing speech-generated oral fluid droplets with laser light scattering (Review by Khatcher Margossian, MS2/PhD student)

  • A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV (Review by Luke McCormack, MS2)

  • High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. (Review by Ndubisi Onah, MS3)

  • Phylogenetic network analysis of SARS-CoV-2 genomes. (Review by Emily Hejna, MS2)

  • Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors (Review by Steven Heidt, MD)

  • A multi-basic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells (Review by Luke McCormack, MS2)

Back to top


Epidemiology

  • All-Cause Excess Mortality and COVID-19-Related Mortality Among US Adults Aged 25-44 Years, March-July 2020 (Alex Hodakowski, M1) 

  • Assessment of 13 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States (Kat Tehaney, M2)  

  • Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19 (Review by Alex Hodakowski, MS1)

  • Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America (Review by Alex Hodakowski, MS1)

  • Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Review by Lauren Grimm, MS1) 

  • Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020 (Review by Alex Hodakowski, MS2) 

  • Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic (Review by Alejandro Javier Paulino, MS4)  

  • Epidemiology and clinical features of coronavirus disease 2019 in children (Review by Alice Burgess, MS2)

  • Comparison of hospitalized patients with acute respiratory distress syndrome caused by COVID-19 and H1N1 (Review by Bryant Yu, MS2)

  • The reproductive number of COVID-19 is higher compared to SARS coronavirus (Review by Conor Flavin, MS3)

  • Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? (Review by Joseph Dodson, MS1)

  • First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: A modelling impact assessment (Review by Connon Wakefield, MS3)

  • Epidemiology of 2019 Novel Coronavirus Disease-19 in Gansu Province, China, 2020 (Review by Antonios Skondras, MS2)

  • Spread of SARS-CoV-2 in the Icelandic population (Review by Gary Wu, MS3)

  • Temporal dynamics in viral shedding and transmissibility of COIVD-19 (Review by Steven Heidt, MS4)

  • Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 – COVID-NET, 14 States, March 1-30, 2020 (Review by Elena Perkins, MS3)

  • Epidemiology of COVID-19 among children in China (Review by Grace Alexander, MS2)

  • The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak (Review by Alice Burgess, MS2)

  • Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS (Review by Travis Tran, MS2)

  • Universal Screening for SARS-CoV-2 in Women Admitted for Delivery (Review by Alice Burgess, MS2)

  • Duration for carrying SARS-CoV-2 in COVID-19 patients (Review by Bryant Yu, MS2)

  • Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study (Review by Steven Heidt, MD)

  • The impact of nutrition on COVID-19 susceptibility and long-term consequences.(Review by Alice Burgess, MS2)

  • Asymptomatic SARS-CoV-2 infection in household contacts of a healthcare provider, Wuhan, China. (Review by Antonios Skondras, MS2)

  • High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. (Review by Grace Alexander, MS2)

  • A systematic review of COVID-19 epidemiology based on current evidence. (Review by Kelly Harmon, MS1)

  • Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. (Review by Steven Heidt, MD)

  • Clinical characteristics and risk assessment of newborns born to mothers with COVID-19. (Review by Gary Wu, MS3)

  • Factors associated with prolonged viral RNA shedding in patients with COVID-19. (Review by Elena Perkins, MS3)

  • Cardiovascular disease, drug therapy, and mortality in COVID-19. (Review by Kavya Timmireddy, MS3)

  • Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. (Review by Bryant Yu, MS3)

  • Association of Public Health Interventions with the Epidemiology of the COVID-19 Outbreak in Wuhan, China. (Review by Steve Heidt, MD)

  • Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. (Review by Susan Mari, MS2)

  • Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. (Review by Gary Wu, MS3)

  • SARS-CoV-2 infection (COVID-19) in febrile infants without respiratory distress. (Review by Bryant Yu, MS3)

  • Demographic science aids in understanding the spread and fatality rates of COVID-19 (Review by Steven Heidt, MD)

  • Identifying and interrupting superspreading events—implications for control of severe acute respiratory syndrome coronavirus 2. (Review by Natalie Maltby, MS1)

  • Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area (Review by Elena Perkins, MS3)

  • Community transmission of SARS-CoV-2 at two family gatherings—Chicago, Illinois, February - March 2020. (Review by Natalie Maltby, MS1)

  • Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. (Review by Steven Heidt, MD)

  • The association between international and domestic air traffic and the coronavirus (COVID-19) outbreak. (Review by Elena Perkins, MS3)

  • Changes in SARS-CoV-2 positivity rate in outpatients in Seattle and Washington state, March 1-April 16, 2020. (Review by Antonios Skondras MS2)

  • Thinking Globally, Acting Locally—The U.S. Response to Covid-19. (Review by Ritika Dhawan, MD)

  • Coronavirus disease outbreak in call center, South Korea. (Review by Antonios Skondras, MS2)

  • Clinical characteristics of patients hospitalized with coronavirus disease, Thailand. (Review by Natalie Maltby MS1)

  • Comparison of estimated rates of coronavirus disease 2019 (COVID-19) in border counties in Iowa without a stay-at-home order and border counties in Illinois with a stay-at-home order (Review by Antonios Skondras, MS2)

  • Estimating the Infection Fatality Rate Among Symptomatic COVID-19 Cases in the United States (Review by Alexandria Taphorn, MS3)

Back to top


Pathogenesis

  • Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19 (Review by Katie Sinchek, MS3)

  • Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study (Review by Mohammed Abdul Sami, MS1)

  • Delirium in older patients with COVID-19 presenting to the emergency department (Amanda Narkis, MS3)

  • Diaphragm pathology in critically ill patients with COVID-19 and postmortem findings from 3 medical centers. (Review by Alex Hodakowski, MS1)

  • SARS-CoV2 transmission from people without COVID-19 symptoms. (Review by Robert Roth, MS1)

  • Changes in preterm birth phenotypes and stillbirth at 2 Philadelphia hospitals during the SARS-CoV-2 pandemic, (Review by Robert Roth, MS1)

  • Household Transmission of SARS-CoV-2. A Systematic Review and Meta-analysis (Amanda Narkis, M3)  

  • Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts (Review by Melissa Porterhouse, M1) 

  • Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 (Muhammed Abdul Sami, MS1)

  • Autopsy findings and venous thromboembolism in patients with COVID-19 (Review by Alex Hodakowski, MS1)

  • Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units (Review by Abigail Bawden, MS2)

  • Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic Stroke (Review by Carter Do, MS1)

  • Incidence of thrombotic complications in critically ill ICU patients with COVID-19 (Review by Alexander Hodakowski, MS1)

  • COVID-19: unanswered questions on immune response and pathogenesis (Review by Mohammed Abdul Sami, M1)

  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review (Review by Abigail Bawden, MS2) 

  • SARS-CoV-2 Infection in Children (Review by Leah Greenfield, MS2) 

  • Multisystem Inflammatory Syndrome in U.S. Children and Adolescents (Review by Mohammed Abdul Sami, M1)

  • Covid-19 in Critically Ill Patients in the Seattle Region - Case Series (Review by Carter Do, MS1)

  • Pathogenesis of COVID-19 from a cell biology perspective (Review by John Bretzman, MS4)

  • Molecular immune pathogenesis and diagnosis of COVID-19 (Review by Rob Destefano, MS4)

  • Hypothesis for potential pathogenesis of SARS-CoV-2 infection - A review of immune changes in patients with viral pneumonia (Review by Kaitlyn Wehrheim, MS2)

  • Evidence for gastrointestinal infection of SARS-CoV-2 (Review by Alex Hornung, MS1)

  • Rates of co-infection between SARS-CoV-2 and other respiratory pathogens (Review by Kevin Grudzinski, MS2)

  • Liver injury in COVID-19: Management and challenges (Review by Dallas Kramer, MS3)

  • Description and proposed management of the acute COVID-19 cardiovascular syndrome (Review by Adithya Sivakumar, MS1)

  • Pathological findings of COVID-19 associated with acute respiratory distress syndrome (Review by Alex Hornung, MS1)

  • Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model (Review by John Levinson, MS2)

  • Characteristics and mechanism of liver injury in 2019 coronavirus disease (Sameera Khan, MS1)

  • SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes (Review by Danesha Lewis, PhD student)

  • Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases (Review by Alex Hornung, MS1)

  • SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (Review by John Bretzman MD)

  • Human leukocyte antigen susceptibility map for SARS-CoV-2 (Review by Sameera Khan, MS1)

  • Virology, epidemiology, pathogenesis, and control of COVID-19 (Review by Mira Marchioretto, MS2)

  • SARS-CoV-2 infection in pregnancy - A review of the current literature and possible impact on maternal and neonatal outcome (Review by Kaitlyn Wehrheim, MS2)

  • Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: A preliminary report of the first 28 patients from the Korean cohort study on COVID-19 (Review by Kelly Harmon, MS1)

  • Liver injury during highly pathogenic human coronavirus infections (Review by Bijan Zarrabi, MS2)

  • Cardiovascular complications in patients with COVID-19: Consequences of viral toxicities and host immune response. (Review by Kaitlyn Wehrheim, MS2)

  • Reduction and functional exhaustion of t cells in patients with coronavirus disease 2019 (COVID-19). (Review by Kaitlyn Wehrheim, MS2)

  • Cardiovascular disease and COVID-19. (Review by John Bretzman, MD)

  • Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management. (Review by Al Hornung, MS1)

  • Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. (Review by Rob DeStefano, MD)

  • Gastrointestinal manifestation of SARS-CoV_2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. (Review by Kelly Harmon, MS1)

  • Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword? (Review by Dallas Kramer, MS3)

  • Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. (Review by Megan Kotzin, MS1)

  • Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19. (Review by Al Hornung, MS1)

  • Complex immune dysregulation in COVID-19 patients with severe respiratory failure. (Review by Al Hornung, MS1)

  • Acute kidney injury in SARS-CoV-2 infected patients. (Review by Megan Kotzin, MS1)

  • Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19. (Review by John Levinson, MS2)

  • Alterations in Smell or Taste in Mildly Symptomatic Outpatients with SARS-CoV-2 Infection. (Review by Kevin Grudzinski, MS2)

  • Inhibitors of the renin–angiotensin system: The potential role in the pathogenesis of COVID-19. (Review by Clara Ledsky, MS2)

  • Guillain-Barre syndrome associated with SARS-CoV-2. (Review by Mira Marchioretto, MS2)

  • COVID-19 Coagulopathy in Caucasian patients. (Review by Al Hornung, MS1)

  • Elevated interleukin-6 and severe COVID-19: A meta-analysis. (Review by Dallas Kramer, MS3)

  • Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). (Review by Dallas Kramer, MS3)

  • SARS-CoV-2 and Viral Sepsis: Observations and Hypothesis. (Review by Kaitlyn Wehrheim, MS2)

  • Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19. (Review by Robert DeStefano, MD)

  • Dysregulation of immune response in patients with COVID-19 in Wuhan, China. (Review by Kaitlyn Wehrheim, MS2)

  • Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. (Review by Samantha Betman, MS3)

  • Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. (Review by Dallas Kramer, MS3)

  • A dynamic immune response shapes COVID-19 progression. (Review by Al Hornung, MS1)

  • The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. (Review by Adithya Sivakumar, MS1)

  • Acute Hyperglycemic crises with coronavirus disease-19: Case reports. (Review by Al Hornung, MS1)

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: A systematic review. (Review by Samantha Betman, MS3)

  • The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. (Review by Rob DeStefano, MD)

  • Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study. (Review by Kaitlyn Wehrheim, MS2)

  • D-Dimer Levels on Admission to Predict In-Hospital Mortality in Patients with Covid-19. (Review by Samantha Betman, MS3)

  • Endothelial cell infection and endotheliitis in COVID-19. (Review by Kevin Grudzinski, MS2)

  • Virological assessment of hospitalized patients with COVID-2019 (Review by Rob DeStefano, MD)

  • Pulmonary embolism in COVID-19 patients: Awareness of an increased prevalence (Review by Samantha Betman, MS3)

  • Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia (Review by Kevin Grudzinski, MS2)

  • Viral and host factors related to the clinical outcome of COVID-19 (Review by Kelly Harmon, MS1)

  • High Fluorescent Lymphocytes Are Increased in COVID-19 Patients (Review by Kelly Harmon, MS1)

  • Postmortem Examination of Patients With COVID-19 (Review by Kelly Harmon, MS1)

Back to top


Diagnosis

  • Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants (Review by Sonia Mehra, MS3)
  • Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience (Review by Emily He, MS3)
  • Serum Amyloid A is a biomarker to distinguish the severity and prognosis of coronavirus disease 2019 (COVID-19) (Review by Kelsey Danley, MS4)
  • Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? (Review by Paul Parker, MS4)
  • COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals (Review by Wendy Tian, MS4)
  • Profiling early humoral response to diagnose novel coronavirus disease (COVID-19) (Review by Hannah Raff, MS3)
  • Clinical Characteristics of Coronavirus Disease 2019 in China (Review by Andy Wu, MS2)
  • Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: A multicenter study (Review by Ahmet Sakiri, MS2)
  • Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19). (Review by Kelsey Danley, MD)
  • Evaluation of Nucleocapsid and spike protein-based ELISAs for detecting antibodies against SARS-CoV-2. (Review by Paul Parker, MD)
  • Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis. (Review by Emily He, MS3)
  • A preliminary study on the ultrasonic manifestations of peripulmonary lesions of non-critical novel coronavirus pneumonia (COVID-19). (Review by Nick Sytsma, MD)
  • Ultrastructural evidence for direct renal infection with SARS-CoV-2. (Review by Hannah Raff, MS3)
  • Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019. (Review by Kelsey Danley, MD)

Back to top


Critical Care

  • Cerebral Ischemic and Hemorrhagic Complications of Coronavirus Disease 2019 (Dallas Kramer, MS4)  
  • Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature (Review by Dallas Kramer, MS1)
  • Pediatric Airway Management in COVID-19 Patients: Consensus Guidelines From the Society for Pediatric Anesthesia’s Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society (Review by Matthew Greydanus, MS1)
  • Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic (Review by Alejandro Javier Paulino, MS4)
  • Novel Approach to Reduce Transmission of COVID-19 During Tracheostomy (Review by Aliya Rodriguez, MS1)
  • Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure (Review Emily Hejna, MS3)
  • COVID-19 pandemic: what every otolaryngologist–head and neck surgeon needs to know for safe airway management (Review by Muhammed Abdul Sami, MS1) 
  • Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from Coronavirus Disease 2019 (Review of Natalie Maltby, MS2)
  • Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19) (Review by Alex Hodakowski, MS1)
  • Successful COVID-19 rescue therapy by extra-corporeal membrane oxygenation (ECMO) for respiratory failure: a case report (Review by Emily Chi, MS4)
  • Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series (Review by Aliya Rodriguez, MS1)  
  • Lidocaine During Intubation and Extubation in Patients with Coronavirus Disease (COVID-19) (Review by Carter Do, MS1) 
  • Neurological manifestations of COVID-19: a systematic review (Review by Alejandro Javier Paulino, MS4)  
  • Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients (Review by Reilly Frauchiger-Ankers, MS1)
  • High-flow nasal-oxygenation-assisted fiberoptic tracheal intubation in critically ill patients with COVID-19 pneumonia (Review by Shyam Desai, MS4)
  • COVID-19 Infection Implications for Perioperative and Critical Care Physicians (Review by Beth Hall, MS4)
  • Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan’s Experience (Review by Nick Sytsma, MS4)
  • Practical considerations for performing regional anesthesia: lessons learned from the COVID-19 pandemic (Review by John Sweeney, MS3)
  • Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic. (Review by Nick Sytsma, MD)
  • Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19 (Review by Nick Sytsma, MD)
  • Initial Clinical Impressions of the Critical Care of COVID-19 Patients in Seattle, New York City, and Chicago (Review by Nick Sytsma, MD)

Back to top


Treatment - Combination and Review

  • Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report (review by Mohammed Abdul Sami, MS1) 
  • Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019 (Review by Robert Roth, MS1)  
  • Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19 (Review by Alex Hodakowski, MS1) 
  • Clinical and microbiological effects of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study (Review by Christina Brown, MS2)
  • Management of COVID-19 Respiratory Distress (Review by Eric Moyer, MD)
  • Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (Review by Eric Moyer, MD)
  • Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. (Review by Sarah Sun, MS2)
  • Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro (Review by Maria Amir)
  • Some Drugs for COVID-19 (Review by Demetrios Geanon, MS3)
  • Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID‐19) Pneumonia in Shanghai, China. (Review by Athena Jane Manatis-Lornell MS1)
  • Current evidence for directed and supportive investigational therapies against COVID-19. (Review by Christi Brown, MS2)
  • Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. (Review by Ashley Wehrheim, MS2)
  • Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 (Review by Emily Chi, MS3)

Back to top


Treatment - Hydroxychloroquine

  • Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients with COVID-19: A Randomized Clinical Trial (Review by Alex Hodakowski, M3)
  • Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data (Review by Carter Do, MS1)
  • Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing (Review by Abigail Bawden, MS2)
  • A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for COVID-19 (Review by Dallas Kramer, MS4) 
  • Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial (Review by Joseph deBettencourt, MS3)
  • Chloroquine and hydroxychloroquine in covid-19. (Review by Amanda Narkis, MS2)
  • Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial (Review by Joseph deBettencourt, MS3)
  • A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19) (Review by Joseph deBettencourt, MS3)
  • Observational study of hydroxychloroquine in hospitalized patients with COVID-19. (Review by Kavya Timmireddy, MS3)
  • Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (Review by Joseph deBettencourt, MS3)
  • Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit (Review by Steven Heidt, MD)
  • Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19) (Review by Steven Heidt, MD)
  • Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State (Review by Steven Heidt, MD & Hannah Raff, MS4)

Back to top


Treatment - Lopinavir/Ritonavir

  • Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial. (Review by Demetrios Geanon, MS3)
  • Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19. (Review by Demetrios Geanon, MS3)
  • A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 (Review by Ashley Wehrheim, MS2)
  • Clinical Efficacy of Lopinavir/Ritonavir in the Treatment of Coronavirus Disease 2019. (Review by Manvita Tatavarthy, MS2)

Back to top


Treatment - Plasma Therapies

  • Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia (Review by: Robert Roth, MS1)
  • Treatment of 5 critically ill patients with COVID-19 with convalescent plasma (Review by Amanda Narkis, MS2)Vaccine development
  • The feasibility of convalescent plasma therapy in severe COVID-19 patients: A pilot study (Review by Manvita Tatavarthy, MS2)
  • High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019 (Review by Karina Oelerich, MS2)
  • Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea (Review by Christina Brown, MS2)
  • Effectiveness of convalescent plasma therapy in severe COVID-19 patients (Review by Ashley Wehrheim, MS2)
  • Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection (Review by Sarah Sun, MS2)
  • Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. (Review by Maria Amir, MS2)

Back to top


Treatment - Remdesivir

  • Case reports study of the first five patients COVID-19 treated with remdesivir in France (Review by Carter Do, MS1)
  • Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. (Review by Ashley Wehrheim, MS2)
  • Compassionate use of remdesivir for patients with severe Covid-19 (Review by Ayesan Rewane, MSCR)

Back to top


Treatment - Tocilizumab

  • Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study (Review by Alex Hodakowski, MS2) 
  • Tocilizumab Challenge: A Series of Cytokine Storm Therapy Experiences in Hospitalized COVID-19 Pneumonia Patients (Review by Alex Hodakowski, MS1)
  • Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: A cautionary case report (review by Mohammed Abdul Sami, MS1) 
  • Tocilizumab for the treatment of severe coronavirus disease 2019 (Review by Monique Holod, MS1)
  • Tocilizumab treatment in COVID‐19: A single center experience. (Review by Amanda Narkis, MS2)
  • Effective treatment of severe COVID-19 patients with tocilizumab (Review by Ashley Wehrheim, MS2)
  • Off‐label use of tocilizumab in patients with SARS‐CoV‐2 infection. (Review by Maria Amir, MS2)
  • Letter to the Editor: Acute hypertriglyceridemia in patients with COVID‐19 receiving tocilizumab. (Review by Amanda Narkis, MS2)
  • Tocilizumab for the Treatment of Severe COVID‐19. (Review by Amanda Narkis, MS2)
  • Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE) (Review by Kavya Timmireddy, MS3)

Back to top


Treatment - Other

  • Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients (Review by Natalie Maltby, MS2)
  • Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports (Review by Robert Roth, MS2)
  • Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial(Alex Hodakowski, M1) 
  • Monoclonal Antibodies for Prevention and Treatment of COVID-19 (Review by Lauren Grimm, MS1)  
  • Integrated Survival Estimates for Cancer Treatment Delay Among Adults with Cancer During the COVID-19 Pandemic (Review by Alex Hodakowski, M3)
  • COVID-19: Melatonin as a potential adjuvant treatment (review by Christopher Szewczyk, MS1) 
  • Famotidine Use and Quantitative Symptom Tracking for COVID-19 in Non-Hospitalised Patients: A Case Series (Review by: Melissa Porterhouse, MS1)
  • Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19) (Review by Aliya Rodriguez, MS1)
  • Early Outcomes with Utilization of Tissue Plasminogen Activator in COVID-19 Associated Respiratory Distress: A Series of Five Cases (Review by Melissa Porterhouse, MS1)
  • Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19). (Review by Joseph deBettencourt, MS3)
  • Creating a framework for conducting randomized clinical trials during disease outbreaks. (Review by Ayesan Rewane, MSCR)
  • COVID-19 infection and rheumatoid arthritis: Faraway, so close! (Review by Danesha Lewis, PhD student)
  • Traditional Chinese and Western Medicines Jointly Beat COVID-19 Pandemic. (Review by Sarah Sun, MS2)
  • Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) (Review by Eric Moyer, MD)
  • Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV (Review by Caleb Bailie, MS1)
  • Prevention and Therapy of COVID-19 via Exogenous Estrogen Treatment for Both Male and Female Patients; An Opinion Paper (Review by Ashley Wehrheim, MS2)
  • Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. (Review by Maria Amir, MS2)
  • Flooded by the torrent: The COVID-19 drug pipeline. (Review by Joseph deBettencourt, MS3)
  • Experimental treatment with favipiravir for COVID-19: an open-label control study (Review by Karina Oelerich, MS2)
  • A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. (Review by Ashley Wehrheim, MS2)
  • Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19. (Review by Joseph deBettencourt, MS3)
  • Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. (Review by Ashley Wehrheim, MS2)
  • Myth Busters: Dietary Supplements and COVID-19 (Review by Joseph deBettencourt, MS3)
  • SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? (Review by Abigail Bawden, MS1)

Back to top


Vaccine Development

  • SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents (Review by Natalie Maltby, MS2)

  • Protection against Covid-19 by BNT162b2 Booster across Age Groups (Review by Alex Hodakowski, MS2)

  • Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines (Review by Natalie Maltby, MS2)

  • BNT162b2 Vaccine Booster and Mortality Due to Covid-19 (Review by Carter Do, MS2)

  • Antiboy Titers Before and After a Third Dose of the SARS-CoV-2 BNT 162b2 Vaccine in Adults ≥ 60 Years (Review by Chris Szewcyk, MS2)

  • Vaccine effectiveness against SARS-CoV-2 Infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish Cohort Study (Review by Timothy Kuzel, MS3)

  • Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters (Review by Robert Roth, MS1)

  • Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US – December 14, 2020 – January 18, 2021 (Review by Robert Roth, MS1)

  • Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration (Lauren Grimm, MS1)

  • An mRNA Vaccine against SARS-CoV-2 – Preliminary Report (Review by Ashley Wehrheim, MS3)  

  • ChAdOxI nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques (Review by Leah Greenfield, MS1)

  • SARS-CoV-2 and SARS-CoV spike-RBD structure and receptor binding comparison and potential implications on neutralizing antibody vaccine development (Review by John Sweeney, MS3)

  • Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV ): a systematic review (Review by Leah Greenfield, MS1)

  • The COVID-10 vaccine development landscape (Review by Leah Greenfield, MS1)

  • An effective CTL peptide vaccine for Ebola Zaire based on survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design (Review by Emily Beltran, MS1)

  • COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics (Review by Ahmad Gill, MS3)

  • Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic (Review by Morgan Sturgis, MS2)

  • Multi-epitope vaccine design using an immunoinformatics approach for 2019 novel coronavirus in China (SARS-CoV-2) (Review by Audrey Sung, MS3)

  • Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine induces equivalent preclinical antibody titers and viral neutralization to recovered COVID-19 patients (Review by Leah Greenfield, MS1)

  • In silico Design of novel Multi-epitope recombinant Vaccine based on Coronavirus surface glycoprotein (Review by Ahmad Gill, MS3)

  • Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein (Review by Yereida Gallardo, MS1)

  • If a coronavirus vaccine arrives, can the world make enough? (Review by Morgan Sturgis, MS2)

  • Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus. (Review by Johanna Balas, MS1)

  • Insights into cross-species evolution of novel human coronavirus 2019-nCoV and defining immune determinants for vaccine development. (Review by Yereida Gallardo, MS1)

  • Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. (Review by Pranita Kaginele, MS2)

  • Strategies for vaccine design for corona virus using Immunoinformatics techniques. (Review by Audrey Sung, MS3)

  • Epitope-based peptide vaccine design and target site characterization against novel coronavirus disease caused by SARS-CoV-2. (Review by Sharice Hall, MS1)

  • Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains. (Review by Ahmad Gill, MS3)

  • Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. (Review by Yereida Gallardo, MS1)

  • DNA vaccine protection against SARS-CoV-2 in rhesus macaques (Review by Leah Greenfield, MS1)

Back to top


Infection Control/Prevention

  • SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection. (Review by Samantha Betman, MS3)

Back to top